US Patent Issued to Credentis on Jan. 27 for "Self-assembling peptides in the prevention and treatment of cavitated carious lesions" (Swiss, American Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,300, issued on Jan. 27, was assigned to Credentis AG (Windisch, Switzerland).

"Self-assembling peptides in the prevention and treatment of cavitated carious lesions" was invented by Dominikus Amadeus Lysek (Windisch, Switzerland), Michael Hug (Zofingen, Switzerland) and Brian B. Novy (Quincy, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is in the field of caries prevention and treatment, in particular minimally-invasive, or non-invasive dental decay treatment. It relates to a composition and a kit comprising a self-assembling peptide, such as the self-assembling peptide P11-4 or P11-8, and a dental agent, namely a dental sealan...